Telomir Pharmaceuticals TELO Q4 2025 Earnings WiderthanExpected Loss Amid Ongoing Development NEOV Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction FNB Q1 2026 Earnings Slight EPS Miss as Stock Edges Lower NBHC Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment Despite Resilient Operations LMRI Q1 2026 Earnings EPS Surges Past Expectations by 45 Stock Edges Lower ZS Q1 2026 Earnings EPS Surprises to the Upside Amidst Growth Focus